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Abstract: Animal-assisted interventions are widely implemented in different contexts worldwide.
Particularly, animal-assisted therapies and animal-assisted activities are often implemented in
hospitals, rehabilitation centers, and other health facilities. These interventions bring several benefits
to patients but can also expose them to the risk of infection with potentially zoonotic agents. The dog
is the main animal species involved used in these interventions. Therefore, we aimed at collecting
data regarding the occurrence of the pathogens ESKAPE (Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) in dogs,
in order to draft guidelines concerning the possible monitoring of dogs involved in animal-assisted
therapies and animal-assisted activities in healthcare facilities. We performed a literature search using
the PRISMA guidelines to examine three databases: PubMed, Web of Science, and Scopus. Out of
2604 records found, 52 papers were identified as eligible for inclusion in the review/meta-analysis.
Sixteen papers reported data on E. faecium; 16 on S. aureus; nine on K. pneumoniae; four on A. baumannii;
eight on P. aeruginosa; and six on Enterobacter spp. This work will contribute to increased awareness
to the potential zoonotic risks posed by the involvement of dogs in animal-assisted therapies,
and animal-assisted activities in healthcare facilities.
Keywords: animal assisted interventions; zoonoses; dogs; one health; ESKAPE
1. Introduction
Animal Assisted Interventions (AAIs) comprise a broad array of planned activities that involve
animals for the purpose of improving human health and wellness. AAIs involve activities with teams
of humans and animals with the aim of achieving therapeutic (Animal Assisted Therapy; AAT) or
educational (Animal Assisted Education; AAE) goals. The AAIs also include Animal-Assisted Activities
(AAA), such as informal interactions/visitations conducted on a volunteer basis by those teams for
motivational, educational, or recreational purposes [1]. AATs provide well-being, promote the health
of the patients [2], and assist in cognitive, emotional–affective, social, and linguistic rehabilitation [3–6].
In particular, results of several studies mainly involving dogs indicate significant benefits of AAT
in people with psychophysical and mental health disorders, such as adults with Autism Spectrum
Disorder [7], as well as Alzheimer disease and other dementias [6,8,9], and also during psychotherapy
for adolescents [10]. As reported by Serpell and colleagues [11], various animal species are used in
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AAIs, but the dog is the most widely used species, especially in the AAT and in the AAA [3,12,13].
In AAT and AAA, patients interact with dogs by inter-specific relationship activities involving as
petting, physical contact, brushing, playing, and strolling with the dog. Shen et al. [12] demonstrated
that bodily contact may contribute significantly to AAT effectiveness. On the other hand, during these
activities, the patients (often very young or old, or immunocompromised) may have physical contact
with the dog’s mucosae and fur, and can be exposed to the bacteria, fungi, and parasites sub-clinically
carried by the dog [14–16]. Therefore, a conflict exists between the need to preserve bodily contact
during AAT and AAA, while reducing the risk of transmission of zoonotic agents.
As reported in scientific literature, different bacterial species can be carried by the dog and
transmitted to humans [17–22].
ESKAPE bacteria (i.e., Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are a group of common
opportunistic pathogens associated mainly with nosocomial infections [23]. The acronym ESKAPE
was used for the first time in 2008 by Rice [23] and was coined to reflect these microorganism’s ability
to escape killing by antibiotics by developing antimicrobial resistance, and challenge eradication by
conventional therapies. The ESKAPE group of bacteria cause significant morbidity and mortality and
increased resource utilization in healthcare facilities [24,25]. Moreover, World Health Organization
(WHO) has recently listed most ESKAPE bacteria in the list of 12 microorganism against which new
antibiotics are urgently needed [26].
Enterococcus faecium is commensal microorganism of the normal gastrointestinal flora in humans
and animals. E. faecium can be transmitted to humans via direct contact with livestock as well as
companion animals [27]. Recently, the results of some studies highlighted the potential for zoonotic
transmission of ampicillin- and vancomycin-resistant E. faecium from the dog [27–30].
Staphylococcus aureus is part of the cutaneous microbiome of animals and humans and is one of the
leading causes of fatal nosocomial infection in humans [31]. It can cause a range of infections, such as
mild-to severe skin and soft tissue infections, endocarditis, osteomyelitis, and fatal pneumonia [32].
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive
Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). MRSA is one of
the most significant bacteria causing both hospital and community-acquired infections in humans [17].
K. pneumoniae is Gram-negative member of the Enterobacteriaceae, considered one of the common
opportunistic agents causing respiratory and urinary tract infections in humans and dogs [33–37].
K. pneumoniae strains have a significant ability to acquire resistance to antibiotics, and as such, it is of a
public health concern. [38]. Marques and colleagues [35] reported the fecal colonization and sharing of
K. pneumoniae clonal lineages between healthy humans and dogs living in close contact, suggesting the
role of dogs as reservoirs of this bacterium.
A. baumannii is the most clinically significant pathogen implicated in human nosocomial
infections [39]. In humans, A. baumannii infections involve mainly the respiratory tract, but meningitis
and urinary tract infections may also occur [40–42]. Animals represent a potential reservoir of
A. baumannii, and the risk of transmission could increase in companion animals which are in direct
contact or closer vicinity to humans [43].
P. aeruginosa is increasingly recognized as an opportunistic pathogen causing chronic and recurrent
infections in both humans and animals [44]. In humans, it causes nosocomial and healthcare-associated
infections in immunocompromised patients [45,46]. Fernandes and colleagues [47] demonstrated a
zoo-anthroponotic transmission (human–to-dog) of VIM-2–producing P. aeruginosa in the household
following a person’s hospital discharge.
Enterobacter spp., particularly E. aerogenes and E. cloacae, have been associated with nosocomial
foci and are considered opportunistic pathogens [48]. Enterobacter spp. can cause numerous types
of infections, including brain abscess, pneumonia, meningitis, septicemia, urinary tract (especially
catheter-related) infections, and intestinal infections [49]. Transmission occurs through direct or indirect
contact of the mucosal surfaces with the host organism [50].
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There are few reports concerning the risks related to infections with ESKAPE bacteria in the
contexts of AAIs, particularly in the AAT, and in the AAA in healthcare facilities. Therefore, the present
review and meta-analysis aims at analyzing the published data on the presence of ESKAPE bacteria in
the dog, in order to assess the risk of zoonotic transmission in these contexts. By our study, we intend
to make an indirect assessment of the zoonotic risk deriving from contact with the dog, assuming its
role as a healthy and/or asymptomatic carrier of ESKAPE bacteria in AAIs, but in particular in AAT
context and in the AAA in healthcare facilities.
2. Materials and Methods
2.1. Framework for Systematic Review of the Literature
This Review and Meta-Analysis was carried out applying the steps established by the PRISMA
(Preferred Reporting Items for Systematic reviews and Meta-Analyses) group [51] as follows:
(1), conduct a database search to obtain potentially pertinent articles, (2) assess the pertinency
of papers (3), evaluate their quality, and (4) extract the data. The search strategy and article screening
process are summarized in Figure 1.
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2.2. Literature Search Strategy and Data Collection
The systematic literature search was performed using the following word strings: Enterococcus
faecium AND “dog”, Staphylococcus aureus AND “dog”, Klebsiella pneumoniae AND “dog”,
Acinetobacter baumannii AND “dog”, Pseudomonas aeruginosa AND “dog”, Enterobacter spp.
AND “dog”. The extracted articles were sorted by the title and abstract and examined to remove
duplicate and irrelevant articles. Only articles reporting original research in English (published or in
press) were included, while reviews, case reports, retrospective analysis studies, comments, letters, etc.,
without reporting original data were excluded. Only articles published between the years 2000 and
2020 were used. Three scientific electronic databases were used: PubMed [52], Scopus [53], and Web of
Science [54].
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2.3. Relevancy Assessment of the Articles
The initially selected articles were classified as eligible for full text review if containing information
about the occurrence of bacteria ESKAPE by dogs; whereas those focusing on the epidemiology of
these bacteria only in humans or in healthcare facilities were excluded. No restrictions were applied
regarding age, breed, health status, and living conditions of dogs, nor to the technique used to detect
and identified bacteria ESKAPE.
The full texts of the recovered articles were examined for eventual inclusion. Papers were selected
if they met the following inclusion criteria:
• Any paper published between January 2000 and January 2020 indicating the presence of one or
more ESKAPE bacteria in dogs.
• Any paper that reported clear details about the type of the samples (swabs, biological specimens,
medical instruments, such as intravenous catheter) and experimental design (number of dogs,
percentage of positive dogs, dog category, health status of dog, geographical area, etc.).
• Any paper reporting the presence of one or more ESKAPE bacteria both in dogs and in humans
(data on human samples were not considered).
Regarding the studies on the presence of Staphylococcus aureus, we have considered only those
concerning MRSA, since the international scientific literature almost exclusively returned papers
indexed on this particular topic.
Studies regarding the biological characteristics (i.e., phenotypic and molecular characterization
of antimicrobial resistance) of strains of ESKAPE bacteria previously isolated from dogs were
excluded. Furthermore, studies that referred to the presence of one or more ESKAPE species reporting
negative results (no positive samples) were also excluded. Likewise, all studies published before
2000 were excluded.
2.4. Quality Evaluation and Data Extraction
Two researchers performed independently the full texts analysis of each record, using a data
extraction form in order to obtain predetermined and methodological clear information qualitative
and quantitative data; inconsistencies anyhow were decided by consensus. Data that consisted of
first author/year of publication, number/type of sampled dogs, dog category, health status of dog,
number of positives, and country and continent were extracted from included eligible articles. All data
were insert in an Excel dataset. The independent researchers examined eligibility of studies according
the criteria reported above, excluding they if there was not methodological enough information.
2.5. Meta-Analysis
Meta-analysis is a method to obtain a weighted average of results from various studies. In this
manuscript we used methods for the meta-analysis of prevalence [55]. As the studies available have
been conducted in different countries and using different kind of sampling procedures, we considered
random-effect models in order to better account for this variability [56]. Moreover, heterogeneity of
studies has been evaluated using I2 [57]. Heterogeneity was considered high for I2 > 50%. With the aim
to investigate the origin of high heterogeneity, according to literature [58,59], we performed a subgroup
analysis using “health status” as grouping variable. Further, in order to appreciate weights for single
studies, we used the inverse variance method with arcsin transformation [60]. The meta-analysis has
been conducted in R (Foundation for Statistical Computing, Vienna, Austria) [61] using the package
metaphor [62]. Forest plots give a commonly used graphical summary of meta-analysis results [63]:
they have been produced to easily visualize studies and averages, and they have been made available
as supplementary material downloadable from the journal website.
Int. J. Environ. Res. Public Health 2020, 17, 3278 5 of 25
3. Results
The preliminary database search returned 2604 reports. Removal of duplicates yielded 1562 single
papers. Each report was considered duplicated when it had the same information regarding the author,
year of publication, name of the peer review, volume issue, and number of pages. All papers that did not
meet the inclusion criteria were excluded, while 52 papers were selected for data extraction and qualitative
analysis. Our results have been organized in seven tables. In the Table 1, most relevant pathogens based
on number of included studies and the different geographical areas were reported, while in the other
Tables 2–7, details of included studies per each ESKAPE bacterium were reported, respectively. Tables 2–7,
include respectively sixteen articles reporting on Enterococcus faecium [27–30,64–75]; sixteen reporting
on Staphylococcus aureus (methicillin resistant) [76–91]; nine reporting on Klebsiella pneumoniae [34,92–99];
four on Acinetobacter baumannii [100–103]; eight on Pseudomonas aeruginosa [45,82,94,98,104–107]; and
six studies reporting on Enterobacter spp. [82,95,98,99,108,109]. The authors point out that some
articles [82,94,95,98,99] provided data on more than one ESKAPE bacterial species, therefore, the same
papers can be found in different tables. In each table, the articles have been placed in descending order,
starting with the most recent.
Table 1. Number of studies of most relevant pathogens in the different geographical areas.
Bacterial Species
Considered Continent
Subtotal of Studies
Africa Americas Asia Europe Oceania
Enterococcus faecium 1 2 3 10 - 16
Staphylococcus aureus 1 5 7 2 1 16
Klebsiella pneumoniae 2 1 4 2 - 9
Acinetobacter baumannii - - - 4 * - 4
Pseudomonas aeruginosa - 2 3 3 - 8
Enterobacter spp. 2 1 2 1 - 6
Total of included Studies 52 *
* The total number of studies was obtained by considering multi-bacterial studies only once [82,94,95,98,99].
3.1. Enterococcus faecium
In our study, a total of 2700 dogs were sampled in the 16 selected papers regarding E. faecium
presence. The number of sampled dogs ranged from a minimum of 32 [67] to a maximum of 479 [75],
while the number of positive dogs was from 3/32 (9.4%) [67] to 124/155 (80.0%) [71]. The type
of samples taken for the isolation of E. faecium in the articles included in this study consisted
of feces [27–30,68,70,71,73,74], urines [64,75], and other types of samples such as rectal [65,66],
oral [67], several [69,72] swabs. Most of the articles (13 out of 16) were carried out on owned
dogs [28–30,64–69,71–73,75], two studies did not show the dog category [70,74], while only one
study carried out the investigation on military working dogs [27]. Of a total of 16 articles found,
6 were performed on healthy dogs [27,30,66,71–73], 3 on healthy and sick dogs [29,64,65], 4 on sick or
hospitalized dogs [67–69,75], while 3 studies showed no indication regarding the health status of the
sampled dogs [28,70,74]. For all details see Table 1.
Meta-Analysis results suggested that the overall prevalence is 0.30 (Confidence Interval (C.I.)
0.17–0.44). Study heterogeneity was I2 = 97%; consequently, we attempted to group the studies
according to “health status of dog” and heterogeneity lowered to I2 = 52% (p < 0.01). All details
regarding the meta-analysis results has been showed in Figure 2.
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Table 2. Data of the included articles regarding the presence of Enterococcus faecium dogs.
First Author,
Year of Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health Status
of Dog
No. of
Positives % Reference
Kirkan, 2019 100 urines Owned Healthyand sick 22 22 [64]
Aslantas, 2019 276 rectalswabs Owned
Healthy
and sick 60 21.7 [65]
van den Bunt, 2018 277 feces Owned Not Available 71 25.6 [28]
Pillay, 2018 36 rectalswabs Owned Healthy 22 12.0 [66]
Bang, 2017 65 feces Militaryworking Healthy 57 87.7 [27]
Oliveira, 2016 32 oralswabs Owned Sick 3 9.4 [67]
Iseppi, 2015 79 feces Owned Healthy 42 36.5 [30]
Espinosa-Gongora,
2015 108 feces Owned
Healthy
and sick 16 14.9 [29]
Kataoka, 2014 84 feces Owned Hospitalized 11 15.7 [68]
Chung, 2014 171 swabs Owned Sick 9 5.3 [69]
Cinquepalmi, 2013 418 feces N.A. Not Available 45 10.76 [70]
Damborg, 2009
183
feces Owned Healthy
42 23.0
[71]
25 19 76.0
Jackson, 2008 155 swabs Owned Healthy 124 80.0 [72]
Damborg, 2008 127 feces Owned Healthy 10 8.0 [73]
Rodrigues, 2002 104 feces Notavailable Not available 44 42.3 [74]
Simjee, 2002 479 urines Owned Sick 13 2.71 [75]
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3.2. Staphylococcus aureus
In the 16 articles included in this study and published from 2007 to 2019, a total of 2228 dogs were
sampled. The positivity of dogs for this bacterium was detected in the following two main categories
of samples: nasal and perineum swabs and nasal samples; in the first, it ranged between 1 (0.5%)
and 25 (5.7%); in the second, between 1 (1.42%) and 8 (12.7%); in the other, samples were ocular swabs,
pyogenic lesions, and generically swabs. In particular, the highest positivity of 8/16 (50.0%) in pyogenic
lesions was reported by Ekapopphan and colleagues [82]; instead, the lowest positivity was reported
by Hanselman and colleagues [90] in nasal and rectal swabs. Out of the searched articles on MRSA
presence in dogs, 13 papers were carried out on owned dogs [76,77,79–82,84,86–91], one study was
conducted on sheltered dogs [78], Tarazi and colleagues [85] sampled owned, stray and farm dogs,
while only one study showed no indication regarding the health status of the sampled dogs [83].
The study conducted by Ekapopphan and colleagues [82] included also the evaluation of P. aeruginosa
and Enterobacter spp. presence. All info regarding the articles about MRSA were included in Table 3.
Table 3. Data of the included articles regarding the presence of Staphylococcus aureus in dogs.
First Author,
Year of
Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health
Status of
Dog
No. of
Positives % Reference
Tabatabaei, 2019 49 nasal andperineum swabs Owned Healthy 2 4.01 [76]
Ma, 2019 303 nasal andperineum swabs Owned Sick 8 2.6 [77]
Huang, 2019 441 nasal swabs Sheltered Healthy 7 1.6 [78]
Yadav, 2018 16 pyogenic lesions Owned Sick 8 50.0 [79]
Rahman, 2018 36 nasal swabs Owned Healthy 4 13.8 [80]
Kaspar, 2018 192 nasal andperineum swabs Owned
Healthy
and Sick 5 2.6 [81]
Ekapopphan,
2018 32 ocular swabs Owned Sick 10 31.25 [82]
Drougka, 2016 92 nasal andperineum swabs
Not
Available Healthy 11 10.8 [83]
Lo Pinto, 2015 70 nasal swabs Owned Sick 1 1.42 [84]
Tarazi, 2015 150 nasal swabs
Owned,
Stray and
Farm
Healthy 8 12.7 [85]
Hoet, 2013 435 nasal andperineum swabs Owned
Healthy
and Sick 25 5.7 [86]
Morris, 2012 47 nasal andperineum swabs Owned Healthy 7 14.8 [87]
Abdel-Moein,
2011 70 swabs Owned
Healthy
and Sick 2 2.9 [88]
Faires, 2009 45 nasal swabs Owned Healthy 3 6.6 [89]
Hanselman,
2008 193
nasal and
rectal swabs Owned
Not
Available 1 0,5 [90]
Sasaki, 2007 57 nasal swabs Owned Hospitalized 1 1.7 [91]
Meta-Analysis results suggested that the overall prevalence is 0.06 (C.I. 0.03–0.10).
Study heterogeneity was I2 = 86%; consequently, we attempted to group the studies according
to “health status of dog” and heterogeneity lowered to I2 = 50% (p < 0.01). All details regarding the
meta-analysis results has been showed in Figure 3.
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3.3. Klebsiella pneumoniae
The nine articles relating to the presence of K. pneumoniae in the dogs and considered for this
study were published from 2002 [99] to 2019 [92]. The included papers reported a number of dogs
that ranged from 50 [94] to 315 [92], for a total of 1448. In the included papers in this study, dogs were
sampled mainly from rectal swabs [92,95–97] and urinary samples [98], while others considered
fecal [93], blood [94], urine and fecal [34] samples, and one study from intravenous catheters [99].
Only one study [95] provided no info regarding the dog category while the other eight papers stated
that sampling had been conducted on owned dogs. Regarding the health status of the sampled dogs,
in one study they were healthy subjects [92], in four studies they were affected by urinary and intestinal
infections [34] or urinary infections [98,99], or they have hospitalized in the Intensive Care Unit for
other diseases [94], in two studies were not declared [92,96], and in two other studies both sick and
healthy dogs [95,97] were sampled. In the Table 4, the information about the presence of K. pneumoniae
in the dogs by the included studies is shown. In addition, Cetin and colleagues [98] conducted a
multi-bacterial study also evaluating the presence of P. aeruginosa and Enterobacter spp.; also Sharif and
colleagues [95] conducted a similar study, also assessing the presence of Enterobacter spp.; as well as
Chanchaithong and colleagues [94] carried out a study which included the evaluation of the presence of
P. aeruginosa; finally, Lobetti and coll. [99] performed their epidemiological study also on the presence
of Enterobacter spp.
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Table 4. Data of the included articles regarding the presence of Klebsiella pneumoniae in dogs.
First Author,
Year of
Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health
Status of
Dog
No. of
Positives % Reference
Hong, 2019 315 rectalswabs Owned
Not
Available 26 8.3 [92]
Zhang, 2018 234 feces Owned Healthy 13 5.55 [93]
Chanchaithong,
2018 50 blood Owned Sick 8 16.0 [94]
Liu, 2017 285 feces andurines Owned Sick 34 12.0 [34]
Sharif, 2017 136 rectalswabs
Not
Available
Healthy
and sick 33 24.2 [95]
Gonzàlez-Torralba,
2016 160
rectal
swabs Owned
Not
Available 1 0.6 [96]
Abdel-Moein,
2014 68
rectal
swabs Owned
Healthy
and Sick 3 2.7 [97]
Cetin, 2003 100 urines Owned Sick 4 4.0 [98]
Lobetti, 2002 100 intravenouscatheters Owned Sick 4 4.0 [99]
Meta-Analysis results suggested that the overall prevalence is 0.07 (C.I. 0.04–0.17).
Study heterogeneity was I2 = 90%; consequently, we attempted to group the studies according
to “health status of dog” and heterogeneity lowered to I2 = 78% (p < 0.01). All details regarding the
meta-analysis results has been showed in Figure 4.
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3.4. Acinetobacter baumannii
Only four papers were included in our study. Regarding the type of samples, two articles [102,103]
carried out rectal and oral swabs, while in one stool samples were taken [100] and in another skin
swabs [101]. The number of positive dogs was less than 10 in all studies. Their percentages ranged
from a minimum of 2.85% (3/205) [100] to a maximum of 8.82% (9/102) [102]; instead, the values shown
by Mitchell and colleagues [101] and from Belmonte and colleagues [103] were 5.00% and 5.07%,
respectively. All studies were conducted on owned dogs. Meanwhile, regarding their health status,
two studies included hospitalized subjects for consultation or hospitalization [102,103], one study
healthy subjects [101], another study healthy and hospitalized subjects [100]. The articles included in
our study regarding the presence of this bacterium in dogs were published from 2014 to 2018. For other
details, see Table 5.
Table 5. Data of the included articles regarding the presence of Acinetobacter baumannii in dogs.
First Author,
Year of
Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health
Status of
Dog
No. of
Positives % Reference
Gentilini, 2018 205 feces Owned Healthy andhospitalized 3 2.85 [100]
Mitchell, 2018 40 skin swab Owned Healthy 2 5.00 [101]
Pailhoriès, 2015 102 rectal andoral swabs Owned Hospitalized 9 8.82 [102]
Belmonte, 2014 138 rectal andmouth swabs Owned Hospitalized 7 5.07 [103]
Meta-Analysis results suggested that the overall prevalence is 0.04 (C.I. 0.02–0.08).
Study heterogeneity was I2 = 23% (p = 0.25). All details regarding the meta-analysis results is
shown in Figure 5.
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3.5. Pseudomonas aeruginosa
The studies included in this Review-Metanalysis were published from 2003 to 2018. The samples
taken in the respective papers were heterogeneous as regards the sampling site (i.e., ocular and ear
swabs) and type (i.e., blood, soft tissue, urine samples). The positivity rate ranged from 2% of urinary
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specimens in the study by Cetin and colleagues [98] and 31.62% of the ear samples in Penna and
colleagues [107]. As shown in Table 5, the percentages of P. aeruginosa positivity in the other included
papers ranged from 5.13 to 20.8% [46,82,94,104–106]. The article with the highest number of dogs
sampled (n = 1182) was made by Ludwig and colleagues [104] who carried out an epidemiology
survey involving different European countries. Only one study [107] provided no info regarding
the dog category while the other seven papers stated that sampling had been conducted on owned
dogs. In addition, all dogs included in papers about the presence of P. aeruginosa were sick of severe
corneal ulcers [82], otitis externa, pyoderma and wounds [46], otitis externa [106,107], urinary tract
infections [98], hospitalized with surgical, urinary, skin, and ear infections [100,101], and inpatient in
Intensive Care Unit [94].
Table 6. Data of the included articles regarding the presence of Pseudomonas aeruginosa in dogs.
First Author,
Year of
Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health
Status of
Dog
No. of
Positives % Reference
Ekapopphan,
2018 32
corneal and
conjunctival swabs Owned Sick 5 20.8 [82]
Chanchaithong,
2018 50 blood Owned Hospitalized 7 14.0 [94]
Ludwig, 2016 1182 soft tissues Owned Hospitalized 160 13.5 [104]
Bernal-Rosas,
2015 135 clinical samples Owned Hospitalized 7 5.13 [105]
Petrov, 2013 193 ear swabs Owned Sick 33 17.0 [106]
Lin, 2012 402 soft tissues Owned Sick 27 6.7 [46]
Penna, 2011 528 ear swabs NotAvailable Sick 167 31.62 [107]
Cetin, 2003 100 urines Owned Sick 2 2.0 [98]
Meta-Analysis results suggested that the overall prevalence is 0.12 (C.I. 0.07–0.19).
Study heterogeneity was I2 = 96%; consequently, we attempted to group the studies according
to “health status of dog” and heterogeneity lowered to I2 = 37.6% (p < 0.01). All details regarding the
meta-analysis results is shown Figure 6.
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3.6. Enterobacter spp.
Six articles were considered eligible for inclusion in this study. All papers were published from
2002 to 2018. The number of dogs sampled ranged between 20 [108] and 136 [95], for a total of
450 dogs in the seven papers included. The prevalent type of specimens was represented by urine
samples [98] and ocular tissues [108], and then by ocular, rectal, and oral swabs [82,95,109]. In addition,
Lobetti and colleagues [99] has been performed their study on intravenous catheters. As shown in
Table 7, the percentages of positivity ranged between 1.0 [99] and 21.3% [95]. Percentage values of
Enterobacter spp. in dog urine were 2.0% [98]; in eye swabs they ranged from 4.2% [82] to 16.6% [108],
while in oral swabs the values were 1.6% [109]; finally, in rectal swabs the values equal to 21.3% [95].
All studies included for the evaluation of the presence of Enterobacter spp. have been carried out on
owned dogs, except the study by Sharif and colleagues [95] which provided no information in this
regard. Of all the papers included, four were conducted on dogs with eye diseases [82,108] and urinary
tract infections [98,99], one on healthy dogs [109], and another on both healthy and sick dogs [95].
Table 7. Data of the included articles regarding the presence of Enterobacter spp. in dogs.
First Author,
Year of
Publication
No. of
Sampled
Dogs
Type of
Samples
Dog
Category
Health
Status of
Dog
No. of
Positives % Reference
Lacerda, 2018 20 conjunctival surfaceand aqueous humor Owned Sick 3 16.6 [108]
Ekapopphan,
2018 32
corneal and
conjunctival swabs Owned Sick 1 4.2 [82]
Sharif, 2017 136 rectal swabs NotAvailable
Healthy
and sick 29 21.3 [95]
Awoyomi, 2014 62 oral swabs Owned Healthy 1 1.6 [109]
Cetin, 2003 100 urines Owned Sick 2 2.0 [98]
Lobetti, 2002 100 intravenouscatheters Owned Sick 1 1.0 [99]
Meta-Analysis results suggested that the overall prevalence is 0.30 (C.I. 0.17−0.44).
Study heterogeneity was I2 = 50% (p = 0.11). All details regarding the meta-analysis results is
shown in Figure 7.
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4. Discussion
Our work aimed to systematically review data on the presence of pathogens bacteria ESKAPE in
dogs, within the period of 2000 to 2019, focusing on the presence, percentage estimates, type of samples
such as swabs and biological samples (i.e., feces, urines), dog category, and geographic distribution
of the study (country and continent). The choice of the factors mentioned above and reported in the
respective tables is related to the possibility of zoonotic transmission of the bacteria of the ESKAPE
group from the dog to the human during AAT and AAA in health context. In particular, considering the
great recent attention to these bacteria causing of nosocomial death by their characteristics of antibiotic
resistance [110], the articles indexed and published in the last twenty years have been considered; the
type of sample performed from the dog was highlighted to assess not only the variety of tropism of
these bacteria but also to make a prediction of the body regions (of the dog) at risk of contamination
and with which the patients/users involved make contact directly or indirectly; in our opinion, it was
also noteworthy to consider the category of belonging of the dog (owned and non-owned) since
the dogs that are involved in the AAIs, and in particular in the AAT, are owned dogs [5,6,111,112].
Finally, we also considered it appropriate to consider the geographical distribution of the studies
obtained in order to have an overview of the interest of researchers in this topic and considering that
AAIs are now widespread all over the world, especially in industrialized countries [113–115].
Our online search returned 52 papers published in different countries of the five Continents
considered later of appropriate quality to provide useful data to evaluate the presence of these bacteria
in the dogs. The geographical distribution of studies regarding ESKAPE bacteria group in the dog,
in the present study is shown in the respective table to each bacterium.
As previously reported, we have considered the papers related to the presence of these bacteria in
dogs since there is a large correlated lack in the control of dogs involved in AAT. In fact, this type of
non-pharmacological therapy is carried out in settings such as hospitals or healthcare facilities and
is often aimed at patients belonging to risk categories (e.g., dialysis patients, hospitalized patients,
and immunosuppressed or immunocompromised patients) [5,116].
Despite the proven risk of these nosocomial opportunistic bacteria and the numerous investigations
carried out both in the medical and veterinary fields, the studies concerning the dog involved in
AAT and AAA in health context are very small. Particularly, the bacteria belonging to the MRSA
group, together with E. faecium, represent the most studied bacteria of the ESKAPE group in the
dog and mentioned in the Guidelines of the American Journal of Infection Control defined by Lefebvre
and colleagues in 2008 [19], as well as in other scientific contributions published in international
and national journals [117–120]. The lack of standardized control programs of ESKAPE in the dogs
involved in AAT at the international level and in worldwide introduces a knowledge gap and makes it
difficult to estimate related risk level for humans and thoroughly investigate transmission potential
dynamics of these pathogens.
4.1. Enterococcus faecium
As reported by Bang and colleagues [27] Enterococci can be transmitted to humans via direct
contact with animals. Moreover, as reported by Cinquepalmi and colleagues [70], the contact between
pets and their owners is closer than in the past, therefore, contamination of urban roads with dog feces
containing multidrug-resistant microorganisms is also a problem for public and environmental health.
In our study, a total of 16 studies have been returned on the E. faecium presence in dogs but none have
been carried out regarding the dogs involved in the AAIs or particularly in AAT and AAA in health
context. Furthermore, as reported by Lefebvre and colleagues [19], dogs involved in AAIs should
undergo health checks for resistant E. faecium as they can play a role in the spread of this nosocomial
pathogen. The first report regarding the presence of E. faecium vancomycin resistant in dogs was made
in 2002 by Simjee and colleagues [75] and the studies of other researchers have resumed with greater
intensity since 2014. Recently, some studies were performed to highlight the transmission of E. faecium
ampicillin- and vancomycin-resistant from the dog to humans [27–30,73]. Differently, Rodrigues and
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colleagues [74] as well as Kataoka and colleagues [68] showed that the strains of E. faecium isolated
in their studies were resistant to many antibiotics but not to vancomycin, indicating that the risk of
transmission of these strains to humans or the transfer of their resistance genes to others is limited
bacteria belonging to the endogenous flora of the human. Almost all the studies included in this
Review-Metanalysis isolated bacteria from feces [27–30] or rectal [65,66], oral [67], and different swabs
were performed in remaining studies [69,72]. Interestingly, more recent studies have reconfirmed the
dog’s status as a carrier of E. faecium but have also demonstrated its horizontal transfer to humans
through contact and licking. Healthy livestock and pets can harbor enterococcal pathogens that can be
transferred through the food chain, as well as through close associations such as embracing and licking
humans [66]. Previously, the study by Jackson and colleagues [72] performed rectal and skin swabs,
signaling the presence of E. faecium not only in the former but also in the neighboring regions of the
abdomen and rear train. Furthermore, dogs (and cats) can act as reserves of antimicrobial resistance
genes that can be transferred from pets to people [72]. Multi-drug resistant E. faecium has been isolated
and identified from dogs with urinary tract infections supporting the hypothesis that enterococci are a
true uropathogen and not just an opportunistic organism [64]. Finally, dogs are frequent carriers of
CC17-related lineages and can play a role in the spread of this nosocomial pathogen [71].
Finally, based on the different clinical conditions of the dogs sampled in the papers included in this
paper, also from the results of the Metanalysis it emerges that there is a greater prevalence of studies
involving healthy [27,30,66,71–73] and “healthy and sick” dogs [29,64,65]. Therefore, in line with what
reported by the American Guidelines [19], it should be mandatory to perform the microbiological
control of the dog in the AAT and in the AAA in health context, avoiding the possible risk of
transmission of E. faecium.
4.2. Staphylococcus aureus
Animal-to-human MRSA infection appears to be more evident in immunocompromised
patients [17]. The bacteria belonging to the MRSA group, together with E. faecium, represent the
bacteria of the ESKAPE group most studied in the dog and mentioned in the already mentioned
Guidelines of the American Journal of Infection Control defined by Lefebvre and colleagues [19], but also
in other scientific contributions published in international and national journals. While very few papers
emphasize the need to monitor the presence of this bacterium in dogs involved in AAIs [117–120].
In line with the elective tropism of the staphylococci for the mucous membranes of the upper respiratory
tract and for the skin, six studies were conducted on nasal swabs, six on nasal and perineal swabs,
two on eye lesions, skin and pyogenic lesions, and one on ear swabs. It is interesting to note that
inter-species transmission has been evaluated in all included studies not only from dog to human but
also between the dog, farm animals and humans. In this regard, it is very interesting to underline the
study by Lo Pinto and colleagues [84], in which the authors highlight the zoonotic risk for dogs of
having a four times higher probability of contracting staphylococcal keratitis if belonging to people
employed in veterinary work. Moreover, Hoet and colleagues [86] suggest that the owner’s profession
was significantly associated, and the dogs owned by veterinarian students had a 20.5-fold probability
(95% CI 4.5−93.6; p-value = 0.01) more likely to be MRSA positive compared to dogs owned by
customers with different professions. The 2018 studies of Yadav and colleagues [79], Rahman and
colleagues [80], and Kaspar and colleagues [81] highlighted the potential risk of transmission of MRSA
strains from farm animals to dogs, highlighting how, again, the latter act as healthy and asymptomatic
carriers of MRSA strains. In addition, the studies by Morris and colleagues [87] and Faires and
colleagues [89] in which the possibility of colonization of dogs when sharing the domestic space with
people or other animals with MRSA infection is evaluated.
Tabatabaei and colleagues [76] showed that pets and veterinarians could be potential sources
of multidrug-resistant methicillin S. aureus (and multidrug-resistant methicillin S. pseudintermedius)
in Iran. Ma and colleagues [77] carried out an epidemiological survey on dogs (and cats) showing a
prevalence of MRSA equal to 2.6%. Dogs had a statistically more significant probability of carrying
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positive coagulase staphylococci than cats (p < 0.001). This study highlights important differences in
the diversity and transport patterns of commensal staphylococci between dogs and cats in Australia.
Huang and colleagues [78] carried out a study on the prevalence and characteristics of MRSA isolated
from animals in shelter in Taiwan. The MRSA strains isolated in this study were like those already
isolated from the human population in the past, indicating potential public health risks. Yadav and
colleagues [79] carried out their study in India, evaluating the presence of MRSA in different animal
species (cattle, buffalo, and dogs). In their article, eight strains of MRSA that exhibited methicillin
resistance and possessed the mecA gene were isolated from dogs. It is interesting to note that the study
by Kaspar and colleagues [81] highlighted the presence in the dog of the MRSA lineages typically
described for cattle, underlining the impact of the spread of multi-drug resistant microorganisms.
Drougka and colleagues [83], through the comparison between genetic markers, have shown that
identical or very similar strains of MRSA spread between animals and veterinary staff. Pets harbor
Panton-Valentine leukocidin (PVL) positive clones which are a possible source for transmission
to humans. Tarazi and colleagues [85] found a strong association between the isolated strains of
MRSA from dogs and those of humans that are in close contact with them (breeding centers and
associated staff).
Pets can host pandemic strains of MRSA while residing in a family with an infected person.
However, the source of MRSA for the animal cannot always be attributed to the human patient [87].
The presence of MRSA in apparently healthy and/or sick dogs makes it an emerging veterinary pathogen
that could be considered a public health burden if widespread in our community outside hospitals [88].
Faires and colleagues [89] underlined the high prevalence of concomitant colonization of MRSA,
and the identification of indistinguishable strains in humans and dogs (and cats) of the same family,
suggesting the possible inter-species transmission of MRSA. Although the prevalence of colonization
of these methicillin-resistant strains (S. pseudintermedius, S. aureus and S. schleiferi subsp. coagulans) was
low, the combined prevalence of 3.1% can be a source of concern for both animal health and the public
one [90].
At last, based on the health status of the dogs sampled in the papers included in our work and also
from the results of the Metanalysis, it emerges that there is a greater prevalence of studies involving
healthy [76,78,80,83,85,87,89] and “healthy and sick” dogs [81,86,88]. Therefore, consistently with what
reported by the American Guidelines [19] and by the scientific contribution of other Authors [15,17,20],
it should be mandatory to perform the microbiological control of the dog involved in the AAT and in
the AAA in health context, to avoid the possible risk of transmission of these bacteria.
4.3. Klebsiella pneumoniae
Recently, the World Health Organization (WHO) published a global priority list of
antibiotic-resistant bacteria and K. pneumoniae have been included in the “Priority 1: Critical”
group (third-generation cephalosporin (3GC)-and/ or carbapenem-resistant Enterobacteriaceae) [26].
Marques and colleagues [36] reported the fecal colonization and sharing of K. pneumoniae clonal lineages
between healthy humans and dogs living in close contact, suggesting the role of dogs as reservoirs of
this bacterium, even though those strains were neither multidrug resistant nor hypervirulent.
The analyzed studies are uniformly distributed with regards to the sampling between rectal
swabs, urinary and fecal samples, in line with the known enteric and urinary K. pneumoniae tropism,
particularly in dogs.
The results of the study by Hong and colleagues [92] indicate the transmission and direct
spread of extended-spectrum cephalosporin (ESC)-resistant Enterobacteriaceae, such as K. pneumoniae,
between humans and pets. Zhang and colleagues [93] support the hypothesis of transfer of resistant
bacteria between man and dog, since CTX-M-1 has been frequently found in fecal dog Enterobacteriaceae,
while it is still rare in human Enterobacteriaceae in Canada, therefore suggesting the transfer of bacteria
resistant to dogs from farm animals or other sources. Chanchaithong and colleagues [94] showed the
high percentage of drug resistance among K. pneumoniae isolates, underlining that in the clinical practice
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of small animals’ routine detection of Extended-Spectrum Beta-Lactamase (ESBL)-producing bacteria is
necessary, using reliable laboratory methods. The data shown by Liu and colleagues [34] highlight the
alarming resistance to beta-lactamase in Klebsiella (and Enterobacter) species of canine origin in India,
emphasizing them as indicators of antimicrobial resistance. Sharif and colleagues [95] emphasize
the need for active surveillance studies on pets that live very close to humans, since inter-species
transmission can occur within the same family. Gonzales-Torralba and colleagues [96] reported the
first report concerning the isolation of bacteria that produce OXA-48 from pets. In particular, the clonal
nature of K. pneumoniae would suggest nosocomial diffusion rather than repeated introduction by
individual patients into the clinic. Abdel-Moein and colleagues [97] highlight the risk of transmission
of K. pneumoniae infections, via the oro-fecal route, which could occur after handling infected pets or
using contaminated objects within families.
From the data of the papers included in this work and from the results of the Meta-analysis,
if on the one hand it emerged that the sampled dogs were mainly sick subjects [34,94,98,99]; on the
other hand in two studies [95,97], both “healthy and sick” dogs were sampled. Instead, Zhang and
colleagues [93] showed the presence of K. pneumoniae in healthy dogs. These findings additionally
elucidate the need to perform the microbiological control of the dogs involved in the AAT and in the
AAA in health context, avoiding the possible risk of transmission of this bacterium and contamination
even in the home context.
4.4. Acinetobacter baumannii
Animals represent a potential reservoir of A. baumannii and can contribute to the dissemination
of new emerging carbapenemases. The risk of transmission could increase in companion animals
which are in more direct contact and closer vicinity with humans and are more prone to transfer or
acquire A. baumannii [43]. In addition, A. baumanni has also been identified on the skin and in feces of
healthy dogs [100,101]. The studies concerning the presence of A. baumannii denote the fairly recent
attention towards this species/bacterial group (from 2014 to 2018) and despite the elective tropism of
A. baumanni for the digestive system, heterogeneity of the samples taken (feces, rectal, oral, and skin
swabs) was reported. Particularly, to be noted as all the studies indicated above were carried out in the
context of veterinary hospitals or veterinary clinics. More specifically, Gentilini and colleagues [100]
estimated the risk of colonization by Gram-negative, non-fermenting carbapenem-resistant bacteria in
pets admitted to veterinary tertiary care centers, highlighting their potential role in the diffusion of
resistance genes between animals and humans. The study reported by Mitchell and colleagues [100]
showed that Acinetobacter spp. they can survive on the skin of dogs, which can become potential
reservoirs of infection. Pailhoriès and coll. [102] have shown that A. baumannii strains are present in
non-hospital settings on Reunion Island but Previously, Belmonte and colleagues [103] had assessed
already the presence of A. baumannii in pets (dogs and cats) hospitalized in nine veterinary clinics on
Reunion Island.
There are very few articles found in the literature and included in our work, therefore it is not
scientifically correct to make conclusive statements on the risk of the transmission of A. baumannii
from dog to man. Considering this, we can only emphasize that the dogs sampled in the study of
Mitchell et at. [101] were healthy and that skin swabs had been performed, emphasizing the need to
carefully monitor the dogs involved in AAT and AAA in the health context, considering the frequent
contact that occurs in the respective settings.
4.5. Pseudomonas aeruginosa
In animals, particularly in dogs and cats, P. aeruginosa causes otitis external/media, corneal ulcers,
urinary tract infection, and pyoderma [82,98,104]. However, only a few studies have highlighted the
potential risk from contact with dogs infected with P. aeruginosa. In this regard, only Lefebvre and
colleagues [20] have evaluated the presence of this bacterium in dogs visiting hospitalized people,
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while very few other studies have considered human–dog–environment transmission in the veterinary
facilities, such as hospital and clinics [46,47,82].
The studies included in this Review-Metanalysis start from 2003 by Cetin and colleagues [98]
(these authors conducted a multi-bacterial study also assessing the presence of K. pneumoniae and
Enterobacter spp.) to arrive at 2018 with the paper by Ekapopphan and colleagues [82], (these authors
also conducted a multi-bacterial study also evaluating the presence of MRSA and Enterobacter spp.).
None of the studies included evaluated the presence of resistant P. aeruginosa in dogs involved in AAI.
For the purposes of our investigation, highlighting the risk resulting from contact with certain body
regions, the data reported by Penna and colleagues [107], which indicates the presence of P. aeruginosa in
cases of canine external otitis and the data reported by Ludwig and colleagues [104] which indicates the
presence of the bacterium in soft tissues, skin, and superficial wounds. As observed in human hospitals,
P. aeruginosa acts as one of the multi-resistant microorganisms of veterinary clinical relevance [105].
Note the study by Lin and colleagues [46] on the antimicrobial resistance profiles of P. aeruginosa strains
of canine origin in China, as it represents the first report of the oxacillin bla-OXA-31 resistance gene of
this bacterium in a canine isolate.
From the data that emerged in our study, it appears clearly that P. aeruginosa causes urinary and
auricular symptoms and infects soft tissues. In fact, all the included studies sampled sick or hospitalized
dogs. Therefore, the risk of transmission to humans is mainly due to contact with symptomatic dogs
but this does not exclude that there may be asymptomatic or reservoir dogs of this bacterium as a
commensal of the urinary tract or ear.
4.6. Enterobacter spp.
Enterobacter spp. have been observed in device-related intravascular infections and surgical site
infections (mainly postoperative or related to devices such as biliary stents). Transmission occurs
through direct or indirect contact of the mucosal surfaces with the infectious agent (e.g., transfer from
contaminated hands to contaminated neonatal units or urinals) or, in the case of endogenous flora,
through transfer to adjacent body sites sensitive and sterile [48–50].
Few papers are present in the literature reporting epidemiological investigation data on the
presence of Enterobacter spp. in dogs, and they considered its presence mainly in urine samples [94],
intravenous catheters [99], ocular [82,108], oral [109], and rectal [95] swabs.
In 2003, Cetin and colleagues [98] were the first to report the presence of Enterobacter spp.,
in association with other bacterial species, in dogs with urinary problems. These authors conducted
a multi-bacterial study evaluating the presence of K. pneumoniae and P. aeruginosa. The attention,
after about 10 years of silence, was then directed to other body regions such as the oral cavity [109],
the rectum [95], to get to the most recent studies of Ekapopphan and colleagues [82] and Lacerda
and colleagues [108], which reported the presence of Enterobacter spp. in ocular swabs (cornea and
conjunctiva). The alarming incidence of beta-lactamase resistance found in this study by Sharif and
colleagues [95], could probably be the result of the indiscriminate use of antibiotics in veterinary
practice, which reflects the possible risk of therapeutic failures that can occur in the treatment of
infections caused by Enterobacter spp. Awoyomi and colleagues [109] highlighted that the oral cavities
of hunting dogs can carry multi-resistant bacteria, of significant importance for public health since
they could be transferred to humans through contaminated hunting tools and bite wounds.
The few studies included in this Review-Metanalysis underline the need not to underestimate
the potential transmission risk of bacteria belonging to the Enterobacter genus, since based on the
antibiotic-resistance data that emerged and the genetic analyzes carried out, these bacteria can be
transferred through the bite wounds and more generally through contact with the dog’s external
mucous membranes.
Finally, from the results of the Metanalysis, the sampled dogs were mostly sick subjects [82,98,99,108]
but Sharif et al. [95] and Awoyomi et al. [109] showed positivity results in “healthy and sick” dogs and
in healthy dogs, respectively. It is interesting to note that all the subjects sampled in the six studies
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concerning Enterobacter spp. included in this Review and Meta-analysis were dogs owned. Our results,
also in this case, require reflection on the need to subject the dogs involved in the AAT and in the AAA
in health context.
4.7. Potential Limitations of the Data
The notable lack of papers on the presence of ESKAPE bacteria in the dog involved in AAT
at the international levels, as well as individual surveys poor representative, might have affected
the true estimates of these zoonoses in individual countries, in the continents and across the world.
This study did not utilized data from abstracts, posters, and conference proceedings but only full
paper publications. Furthermore, the included studies showed a great heterogeneity regarding the
number of dogs sampled and the respective percentages of positivity, as well as the samples taken;
the isolation and identification methods of the individual bacteria were not considered; except for
Staphylococcus aureus methicillin resistant, the inclusion of papers was made considering the resistance
to antibiotics and not to specific antibiotic categories (ampicillin-, vancomycin-, β-lactam resistant).
5. Conclusions
Currently, there is moderate attention by researchers to the role of the dog as a vector of the
bacteria of the ESKAPE group, the international scientific literature is still not very sensitive and is
scarcely aimed at assessing the risk related to the presence of these bacteria in the dogs involved in
the AAT and AAA in the health context. From the literature included in this work it emerges that the
risk of dog–human zoonotic transmission (and vice versa) concerns all bacteria of the ESKAPE group,
therefore the level of surveillance must include mandatory microbiological controls and strong rules
of hygienic and behavioral management of the animal. In this regard, the continuous and constant
health control of the animals involved in the AAIs, with particular reference to the dog, should be a
priority. In fact, the close contact between human and pets determines the risk of zoonosis and creates
opportunities for interspecies transmission of resistant bacteria [121].
In this aim, in our opinion, it is more and more necessary to a One Health approach, which involves
the collaboration between veterinarians, physicians, public health operators, and epidemiologists,
in order to prevent the transmission of such bacteria and to attain optimal health for humans, animals,
and the environment. The AAIs, particularly the AAT, and the AAA in the health context, represent a
concrete example of One Health approach and require necessarily an inter-disciplinary approach as
they involve different health professionals. These operators, each according to their skills, work in
team for people’s health, for the control and protection also of the health and welfare of the animal
involved, for the prevention and control of zoonotic diseases.
Furthermore, we hope to be able to encourage a discussion with international experts regarding
the need to draw up standardized hygiene-health-behavioral monitoring protocols, aimed at producing
health and behavioral certifications valid for all dogs that perform AAT and AAA in the health context.
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